29Nov 2023
Study Finds Common Immunosuppressants Safe in Long-Term Use for Inflammatory Diseases

Study Finds Common Immunosuppressants Safe in Long-Term Use for Inflammatory Diseases

A retrospective cohort study at ocular inflammatory disease (OID) subspecialty centres aimed to determine the incidence of all-cause and cancer mortality associated with immunosuppression. Over a median follow-up of 10.0 years and 187,151 person-years involving 15,938 patients, the study observed 1970 deaths, including 435 due to cancer. Results showed that commonly used immunosuppressants, such as TNF inhibitors and antimetabolites, were not associated with increased overall or cancer mortality. The findings suggest the safety of these agents in patients treated for various inflammatory diseases over the long term.

  • #ophthalmology

Like

Save

Share